Infleqtion, Inc.
INFQ
$14.82
+10.43%
Infleqtion, Inc. is a technology company developing and commercializing a full-stack quantum technology platform, including quantum sensing, quantum computing, and software solutions. The company positions itself as an integrated platform player in the nascent but strategically critical quantum sector, aiming to address challenges in defense, AI, energy, and cybersecurity. The current investor narrative is overwhelmingly driven by significant government funding and sector validation, as evidenced by recent news of a $100 million grant to Infleqtion and a broader $2 billion U.S. government investment in quantum computing, which has fueled a speculative rally and intense debate about the commercial viability and timeline for these pre-revenue technologies.…
INFQ
Infleqtion, Inc.
$14.82
Related headlines
INFQ 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Infleqtion, Inc.'s 12-month outlook, with a consensus price target around $19.27 and implied upside of +30.0% versus the current price.
Average Target
$19.27
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$12 - $19
Analyst target range
Analyst coverage is extremely limited, with only one analyst providing estimates, which implies this is a small-cap, recently listed stock with minimal institutional research interest, leading to higher volatility and less efficient price discovery. The single analyst estimates revenue of $65.63 million and an EPS of -$0.134 for the period in view; no consensus price target, recommendation, or target range is available, preventing any calculation of implied upside or downside or assessment of bullish/bearish sentiment. The lack of traditional analyst targets underscores the speculative, pre-profit nature of the investment, where valuation is driven almost entirely by narrative, technological milestones, and external funding events like government grants rather than fundamental metrics.
INFQ Technical Analysis
The stock is in a volatile recovery phase following a sharp post-IPO decline, with the current price of $13.42 sitting approximately 26% above its 52-week low of $8.52 but 37% below its 52-week high of $21.28, indicating it is recovering from deeply oversold levels but remains well off its peak. The 1-year trend is not calculable from the provided 180-day data, but the 3-month price change of +33.13% shows strong positive momentum, which sharply contrasts with the SPY's +12.0% gain over the same period, highlighting significant relative strength. Recent momentum is highly volatile, with a +0.98% 1-month change underperforming the explosive 3-month gain, suggesting a potential consolidation or pullback after the May rally; the stock's beta is not provided, but the price swing from a low of $8.81 to a high of $19.87 within the data period implies extreme volatility. Key technical levels are clearly defined, with major support at the 52-week low of $8.52 and resistance at the 52-week high of $21.28; a sustained breakout above $21.28 would signal a resumption of the bullish trend fueled by sector catalysts, while a breakdown below $8.52 would indicate a failure of the recovery thesis.
Beta
—
—
Max Drawdown
-43.5%
Largest decline past year
52-Week Range
$9-$21
Price range past year
Annual Return
—
Cumulative gain past year
| Period | INFQ Return | S&P 500 |
|---|---|---|
| 1m | +19.1% | +2.1% |
| 3m | +37.5% | +12.5% |
| 6m | — | +12.4% |
| 1y | — | +26.4% |
| ytd | — | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
INFQ Fundamental Analysis
Revenue trajectory cannot be analyzed from the provided data as quarterly financials and income statements are empty; however, analyst estimates point to expected revenue of approximately $65.6 million, but without historical figures, assessing growth acceleration or deceleration is impossible. The company is deeply unprofitable, with a trailing EPS of -$0.077 and a negative Return on Equity (ROE) of -19.34%, indicating it is burning capital to fund operations and growth with no current return for shareholders; gross, operating, and net margins are all reported as 0%, which is atypical and may indicate immaterial or unrecognized revenue under accounting rules. The balance sheet shows minimal debt with a debt-to-equity ratio of 0, but financial health is concerning with a dangerously low current ratio of 0.014, signaling severe potential liquidity constraints; the negative price-to-cash-flow ratio of -381.1 confirms the company is consuming cash, making it dependent on external financing like the recent government grants to continue operations.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is INFQ Overvalued?
Given the negative net income (EPS of -$0.077), the primary valuation metric selected is the Price-to-Sales (PS) ratio; however, the provided PS ratio is 0, which is nonsensical for a company with estimated revenue, so we must rely on Enterprise Value-to-Sales (EV/Sales) of 78.6x as the most meaningful metric, with no forward PS or EV/Sales available for comparison. Peer comparison is not possible as industry average multiples are not provided in the valuation data, leaving the extraordinarily high EV/Sales multiple of 78.6x without context, though it undoubtedly signals the market is pricing in massive future sales growth from a currently minimal base, typical for a pre-commercial, story-driven quantum stock. Historical context is unavailable as historical ratios data is empty, so we cannot determine if the current valuation is at a historical extreme; the absence of this data is consistent with a newly public company like Infleqtion, which listed on February 17, 2026.
PE
-12.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-12.9x
Enterprise Value Multiple